| 000 | 01894 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513050231.0 | ||
| 264 | 0 | _c19950406 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.1995.tb03303.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRusso-Mancuso, G | |
| 245 | 0 | 0 |
_aEfficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cFeb 1995 |
||
| 300 |
_a291-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntigens, CD _xanalysis |
| 650 | 0 | 4 |
_aB-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 | _aCD4-CD8 Ratio |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aLymphocytosis _ximmunology |
| 650 | 0 | 4 |
_aLymphopenia _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aReceptors, IgG _xanalysis |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_abeta-Thalassemia _xcomplications |
| 700 | 1 | _aDi Gregorio, F | |
| 700 | 1 | _aPassero, E | |
| 700 | 1 | _aSciotto, A | |
| 700 | 1 | _aMazzarino, M C | |
| 700 | 1 | _aMalaponte, G | |
| 700 | 1 | _aSchilirò, G | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 89 _gno. 2 _gp. 291-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.1995.tb03303.x _zAvailable from publisher's website |
| 999 |
_c7872715 _d7872715 |
||